Several new meds
Theres a lot of excitement surrounding several new medications for hep c genotype i.
The most exciting is solvaldi (sobosbuvir) in combination with ledipasvir. Its not yet fda
approved but we anticipate it being marketed within the next 12 months. Its a once daily tablet. The cure rate is 90% plus. This is an interferon
free regimen. This will revolutionize the treatment for hep c.